Department of Radiation Oncology, VU medical center, Amsterdam, The Netherlands.
Department of Radiation Oncology, VU medical center, Amsterdam, The Netherlands.
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):858-866. doi: 10.1016/j.ijrobp.2018.05.048. Epub 2018 May 29.
We implemented magnetic resonance-guided breath-hold stereotactic body radiation therapy in combination with visual feedback using the MRIdian system. Both accuracy of gated delivery and reproducibility of tumor positions were studied.
Tumor tracking is realized through repeated magnetic resonance imaging in a single sagittal plane at 4 frames per second with deformable image registration. An in-room monitor allowed visualization of the tracked gross tumor volume (GTV) contour and the planning target volume (PTV) (GTV + 3 mm), which was the gating boundary. For each delivery, a predefined threshold-region of interest percentage (ROI%) allows a percentage of GTV area to be outside the gating boundary before a beam-hold is triggered. Accuracy of gated delivery and tumor position reproducibility during breath-holds was analyzed for 15 patients (87 fractions) with lung, adrenal, and pancreas tumors. For each fraction, we analyzed (1) reproducibility of system-tracked GTV centroid position within the PTV; (2) geometric coverage of GTV area within the PTV; (3) treatment duty cycle efficiency; (4) effects of threshold ROI% settings on treatment duty cycle efficiency and GTV area coverage; and (5) beam-off latency effect on mean GTV coverage.
For lung, adrenal, and pancreatic tumors, grouped 5th to 95th percentile distributions of GTV centroid positions in the dorsoventral direction, relative to PTV-center of mass (COM), were, respectively, -3.3 mm to 2.8 mm, -2.5 mm to 3.7 mm, and -4.4 mm to 2.9 mm. Corresponding distributions in the craniocaudal direction were -2.6 mm to 4.6 mm, -4.1 mm to 4.4 mm, and -4.4 mm to 4.5 mm, respectively. Mean GTV areas encompassed during beam-on for all fractions were 94.6%, 94.3%, and 95.3% for lung, adrenal, and pancreas tumors, respectively. Mean treatment duty cycle efficiency ranged from 67% to 87% for these tumors. Use of higher threshold-ROI% resulted in increased duty cycle efficiency, at the cost of a small decrease in GTV area coverage. The beam-off latency had a marginal impact on the GTV coverage.
Gated stereotactic body radiation therapy delivery during breath-hold, real-time magnetic resonance guidance resulted in at least 95% geometric GTV coverage in lung, adrenal, and pancreatic tumors.
我们使用 MRIdian 系统实施了磁共振引导的呼吸门控立体定向体部放射治疗,同时结合视觉反馈。研究了门控输送的准确性和肿瘤位置的可重复性。
通过在单个矢状面以每秒 4 帧的速度重复磁共振成像,实现肿瘤跟踪,采用可变形图像配准。室内监视器允许可视化跟踪的大体肿瘤体积(GTV)轮廓和计划靶区(PTV)(GTV+3mm),这是门控边界。对于每次输送,预设的感兴趣区域百分比(ROI%)阈值允许在触发光束暂停之前,GTV 区域的一定百分比位于门控边界之外。我们分析了 15 例(87 个分次)肺部、肾上腺和胰腺肿瘤患者的呼吸门控输送的准确性和肿瘤位置在呼吸暂停期间的可重复性。对于每个分次,我们分析了:(1)系统跟踪的 PTV 内 GTV 质心位置的可重复性;(2)PTV 内 GTV 面积的几何覆盖;(3)治疗工作周期效率;(4)阈值 ROI%设置对治疗工作周期效率和 GTV 面积覆盖的影响;(5)平均 GTV 覆盖的光束关闭延迟效应。
对于肺部、肾上腺和胰腺肿瘤,GTV 质心位置在背腹方向相对于 PTV 质心(COM)的第 5 至 95 百分位分布分别为-3.3mm 至 2.8mm、-2.5mm 至 3.7mm 和-4.4mm 至 2.9mm。相应的头尾方向分布分别为-2.6mm 至 4.6mm、-4.1mm 至 4.4mm 和-4.4mm 至 4.5mm。所有分次的 GTV 面积在光束照射期间分别为肺部、肾上腺和胰腺肿瘤的 94.6%、94.3%和 95.3%。这些肿瘤的平均治疗工作周期效率范围为 67%至 87%。使用更高的阈值 ROI%会导致工作周期效率增加,但 GTV 面积覆盖略有减少。光束关闭延迟对 GTV 覆盖有一定影响。
在呼吸暂停期间进行实时磁共振引导的门控立体定向体部放射治疗,至少可使肺部、肾上腺和胰腺肿瘤的 GTV 几何覆盖达到 95%。